Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Didem Demirbas Cakici, Ph.D.

Concepts (127)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Didem Demirbas Cakici's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Didem Demirbas Cakici has written about over time.
Phosphodiesterase Inhibitors, 3 publications between 2008 and 2011, average publication date September 2009. Schizosaccharomyces, 5 publications between 2008 and 2013, average publication date September 2010. Drug Evaluation, Preclinical, 4 publications between 2008 and 2013, average publication date November 2010. Cyclic AMP-Dependent Protein Kinases, 1 publications between 2010 and 2010, average publication date November 2010. Cyclic GMP, 1 publications between 2010 and 2010, average publication date November 2010. Cyclic Nucleotide Phosphodiesterases, Type 5, 1 publications between 2010 and 2010, average publication date November 2010. Phosphodiesterase 5 Inhibitors, 1 publications between 2010 and 2010, average publication date November 2010. Phosphoric Diester Hydrolases, 1 publications between 2011 and 2011, average publication date December 2010. High-Throughput Screening Assays, 3 publications between 2010 and 2013, average publication date August 2011. Cyclic Nucleotide Phosphodiesterases, Type 4, 1 publications between 2013 and 2013, average publication date August 2013. Leydig Cells, 1 publications between 2013 and 2013, average publication date August 2013. Phosphodiesterase 4 Inhibitors, 1 publications between 2013 and 2013, average publication date August 2013. UTP-Hexose-1-Phosphate Uridylyltransferase, 4 publications between 2016 and 2019, average publication date February 2018. Liver Diseases, 1 publications between 2018 and 2018, average publication date March 2018. Galactose, 4 publications between 2018 and 2019, average publication date July 2018. Metabolism, Inborn Errors, 2 publications between 2018 and 2018, average publication date July 2018. Galactosemias, 6 publications between 2016 and 2020, average publication date September 2018. Erythrocytes, 1 publications between 2019 and 2019, average publication date January 2019. Galactokinase, 2 publications between 2018 and 2020, average publication date May 2019.

To see the data from this visualization as text, click here.
Demirbas Cakici's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (127)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.